Aigen Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Aigen Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,074	Closed	-$200K	–	817
2022 Q2	$200K	Buy	+8,074	New	+$178K	0.03%	456
2022 Q1	–	Sell	-14,010	Closed	-$484K	–	1211
2021 Q4	$484K	Buy	+14,010	New	+$492K	0.03%	639
2020 Q4	–	Sell	-61,740	Closed	-$3.38M	–	1168
2020 Q3	$3.38M	Buy	61,740 +50,380	+443%	+$2.71M	0.43%	41
2020 Q2	$654K	Buy	11,360 +4,294	+61%	+$234K	0.08%	379
2020 Q1	$284K	Buy	+7,066	New	+$300K	0.04%	608

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Aigen Investment Management's CCXI Position: Q3 2022 in Review

Aigen Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 8,074 shares — an estimated $200K sold.

Aigen Investment Management first reported a position in CCXI in Q1 2020 and held it in 5 quarters. The position peaked at $3.38M in Q3 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Aigen Investment Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Aigen Investment Management sold 8,074 ChemoCentryx, Inc. shares in Q3 2022, an estimated $200K.
Aigen Investment Management first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 5 quarters.
Aigen Investment Management's ChemoCentryx, Inc. position peaked at $3.38M in Q3 2020.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Aigen Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.